Orikami
The AI engine Fit Assessment
BetaOrikami leverages machine learning and data analysis to develop digital biomarkers, enhancing therapeutic options and personalizing healthcare for chronic disease management.
Blurb
Orikami is a health data platform.
HQ Location
Netherlands
Founded
2011
Employees
11 - 50
Total funding raised
$659.06K
Last Funding Event
Seed, $659.06K, October 9, 2019
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Biomarker Identification
Developer of medical-grade digital biomarker technology designed to make an impact in chronic disease areas. The company's technology uses an artificial intelligence-powered digital biomarker platform and speeds up the journey from biomarker discovery through validation to delivery at scale, enabling medical specialists to make decision support, treatment support, and patient coaching.